EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...

Brookfield Asset Management (BAM) is awaiting information from Grifols (GRFS) about related-party transactions as it seeks to complete its due ...

Grifols (NASDAQ:GRFS) rose 4% after a report that Brookfield Asset Management (BAM) is still evaluating a takeover of the ...

Brookfield Asset Management is awaiting information from Grifols SA about related-party transactions as it seeks to complete ...

Brookfield fund has failed to raise the nearly €10,000 million needed to acquire 70% of the company and restructure the debt.

Grifols (NASDAQ:GRFS) dropped 3% after a report that Brookfield (BAM) is delaying a takeover bid due to issues raising money ...

BARCELONA, Spain, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced it has ...

BARCELONA - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company, has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate ...

BARCELONA - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company, has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate ...

A successful preclinical study of this potentially innovative therapeutic could lead to an FDA license for one of the first medical treatments for sulfur mustard ocular injury Grifols also plans to ...

The IBEX 35 index has done well this year and is hovering at its highest point since February 2010. It rose to a high of ...